Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 399

1.

Economic implications of treatment guidelines for congestive heart failure.

Shibata MC, Nilsson C, Hervas-Malo M, Jacobs P, Tsuyuki RT.

Can J Cardiol. 2005 Dec;21(14):1301-6.

PMID:
16341301
2.

Multinational economic evaluation of valsartan in patients with chronic heart failure: results from the Valsartan Heart Failure Trial (Val-HeFT).

Reed SD, Friedman JY, Velazquez EJ, Gnanasakthy A, Califf RM, Schulman KA.

Am Heart J. 2004 Jul;148(1):122-8.

PMID:
15215801
4.
5.
6.

Incremental effects of concurrent pharmacotherapeutic regimens for heart failure on hospitalizations and costs.

Skrepnek GH, Abarca J, Malone DC, Armstrong EP, Shirazi FM, Woosley RL.

Ann Pharmacother. 2005 Nov;39(11):1785-91. Epub 2005 Oct 11.

PMID:
16219900
7.

Drug copayment and adherence in chronic heart failure: effect on cost and outcomes.

Cole JA, Norman H, Weatherby LB, Walker AM.

Pharmacotherapy. 2006 Aug;26(8):1157-64.

PMID:
16863491
8.

Adherence to guidelines is a predictor of outcome in chronic heart failure: the MAHLER survey.

Komajda M, Lapuerta P, Hermans N, Gonzalez-Juanatey JR, van Veldhuisen DJ, Erdmann E, Tavazzi L, Poole-Wilson P, Le Pen C.

Eur Heart J. 2005 Aug;26(16):1653-9. Epub 2005 Apr 12.

PMID:
15827061
9.

Economic effects of beta-blocker therapy in patients with heart failure.

Cowper PA, DeLong ER, Whellan DJ, Allen LaPointe NM, Califf RM.

Am J Med. 2004 Jan 15;116(2):104-11.

PMID:
14715324
10.

Pharmacoeconomic considerations in assessing and selecting congestive heart failure therapies.

Levy E, Levy P.

Pharmacoeconomics. 2002;20(14):963-77. Review.

PMID:
12403637
11.

Pharmacological treatment of congestive heart failure in Canada: a description of care in five provinces.

Cox JL, Ramer SA, Lee DS, Humphries K, Pilote L, Svenson L, Tu JV; Canadian Cardiovascular Outcomes Research Team Investigators.

Can J Cardiol. 2005 Mar 15;21(4):337-43.

PMID:
15838560
12.

Utilisation of medications recommended for chronic heart failure and the relationship with annual hospitalisation duration in patients over 75 years of age. A pharmacoepidemiological study.

Maison P, Cunin P, Hemery F, Fric F, Elie N, Del'volgo A, Dubois-Randé JL, Hittinger L, Macquin-Mavier I.

Eur J Clin Pharmacol. 2005 Jul;61(5-6):445-51. Epub 2005 Jun 7.

PMID:
15940531
14.

Effects of angiotensin-converting enzyme inhibitors and digoxin on health outcomes of very old patients with heart failure. SAGE Study Group. Systematic Assessment of Geriatric drug use via Epidemiology.

Gambassi G, Lapane KL, Sgadari A, Carbonin P, Gatsonis C, Lipsitz LA, Mor V, Bernabei R.

Arch Intern Med. 2000 Jan 10;160(1):53-60.

PMID:
10632305
15.

[Cost effectiveness of ACE inhibition in therapy of chronic heart failure in Switzerland: evaluation based on the SOLVD study].

Szucs TD, Goedde M, Berger K, Kiowski W.

Schweiz Med Wochenschr. 1997 Jul 22;127(29-30):1234-41. German.

PMID:
9333933
16.

What is the economic value of digoxin therapy in congestive heart failure patients? Results from the DIG trial.

Eisenstein EL, Yusuf S, Bindal V, Bourassa MG, Horney A, Collins JF, Mark DB; DIG investigators.

J Card Fail. 2006 Jun;12(5):336-42.

PMID:
16762794
17.

Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF): rationale and design.

Fonarow GC, Abraham WT, Albert NM, Gattis WA, Gheorghiade M, Greenberg B, O'Connor CM, Yancy CW, Young J.

Am Heart J. 2004 Jul;148(1):43-51.

PMID:
15215791
18.

Economic outcomes of withdrawal of digoxin therapy in adult patients with stable congestive heart failure.

Ward RE, Gheorghiade M, Young JB, Uretsky B.

J Am Coll Cardiol. 1995 Jul;26(1):93-101.

19.

Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study.

Juurlink DN, Mamdani MM, Lee DS, Kopp A, Austin PC, Laupacis A, Redelmeier DA.

N Engl J Med. 2004 Aug 5;351(6):543-51.

20.

Management of chronic heart failure due to systolic left ventricular dysfunction by cardiologist and non-cardiologist physicians.

McKee SP, Leslie SJ, LeMaitre JP, Webb DJ, Denvir MA.

Eur J Heart Fail. 2003 Aug;5(4):549-55.

Supplemental Content

Support Center